Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.455 USD | +2.22% | -9.38% | -27.62% |
06-14 | Zura Bio Presents Data for the Tibulizumab (Zb-106) Program At Eular 2024 | CI |
06-06 | Zura Bio Limited Announces Formation of a Scientific Advisory Board | CI |